Measles virus vaccine live inhaled - Aktiv-Dry/Serum Institute of India

Drug Profile

Measles virus vaccine live inhaled - Aktiv-Dry/Serum Institute of India

Alternative Names: Inhaled measles virus vaccine - Serum Institute of India/Aktiv-Dry

Latest Information Update: 03 May 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Aktiv-Dry; Serum Institute of India
  • Developer Aktiv-Dry; Centers for Disease Control and Prevention; Serum Institute of India; University of Colorado at Boulder
  • Class Measles vaccines; Viral vaccines; Viruses
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Measles

Most Recent Events

  • 01 Sep 2013 Serum Institute of India completes a phase I trial in Measles (prevention in volunteers) in India (NCT01557699)
  • 01 Mar 2012 Phase-I clinical trials in Measles (prevention in volunteers) in India (Inhalation)
  • 01 Jan 2010 Preclinical trials in Measles in USA (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top